The main message is that GLP-1 therapy behaves more like a long-term risk-reduction treatment than a short-term fix, said Robert Glatter, MD, attending physician in the Department of Emergency Medicine at Lenox Hill Hospital in New York City, and assistant professor of Emergency Medicine at Zucker School of Medicine at Hofstra/ Northwell, in a previous interview
GLP-1 RA therapy should be discontinued under specific clinical conditions to minimize risk
Regulatory agencies have examined the potential for GLP-1 agonists to cause adverse psychiatric effects, including suicidal ideation
Because the hormone slows gastric emptying and affects insulin production, taking multiple doses too close together could increase the risk of gastrointestinal discomfort or hypoglycemia
Heffron, MD, who led the study
According to some scientists, people can reduce their risk of metabolic disorders by 29 to 45 percent with more foundational dietary and lifestyle changes